Adrenaline is the drug of choice for the emergency treatment of severe allergic reactions to food, insect stings, medication, latex, exercise, and other allergens.
EpiPen® is an adrenaline auto-injector (AAI) used for self administration of adrenaline for the emergency treatment of severe allergic reactions (anaphylaxis).
We’re committed to supporting patients with anaphylaxis and have produced a number of resources to help.
Guidelines covering the management of anaphylaxis recommend adrenaline as immediate first-line treatment.
Key features of EpiPen® and detailed prescribing information.
How to use the EpiPen® Trainer and order a training kit.
An online platform for UK healthcare professionals.
You are now leaving this Mylan affiliate site. Mylan is not responsible for the content of the site you are about to visit.
Are you a UK healthcare professional?
This site is intended for UK Healthcare Professionals. If you are a UK patient who has been prescribed Epipen® (adrenaline) Auto-Injector, Please click here.
EPI-2020-0508 Date of preparation: September 2020
© Copyright 2020 Mylan N.V. All rights reserved.
EXPLORE OUR ALLERGY AND RESPIRATORY PORTFOLIO
Dymista® (azelastine hydrochloride / fluticasone propionate)
Sirdupla™ (fluticasone propionate / salmeterol xinafoate)
Mylan UK Healthcare Limited (company registration number 09189103), an English company with a registered office address at 20 Station Close, Potters Bar, Hertfordshire, EN6 1TL (VAT - 421 623 781)
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Mylan by phone 0800 121 8267 or email email@example.com
Across the website you will find news, blogs and product information.
Please note that the website contains promotional and non-promotional material including educational content and resources to help you and your patients.